EVISA - Who we are
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
Information - Pharmacy/Pharmacology
Cisplatin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Cisplatin is classified as an "alkylating agent." (For more detail, see "How Cisplatin Works" section below).
See the complete list of deadlines!
DGMS 2023: 54th Annual Conference of the DGMS
71st ASMS Conference on Mass Spectrometry and Allied Topics
... more Events
What's new on EVISA's web site ?
Chromium speciation by magnetic solid phase extraction on-line with inductively coupled plasma optical emission spectrometry
Determination of Thallium Species in Food Samples by Microextraction and Graphite Furnace Atomic Absorption Spectrometry
Arsenic species in edible mushrooms from central Europe
Online addition of an internal standard for high performance liquid chromatography-inductively coupled plasma mass spectrometry
... more News
You have forgotten your password ?
© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )